The Technology
Cynosure is a leading developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems. Cynosure products are used to provide a diverse range of treatment applications such as hair removal, skin rejuvenation and scar reduction, as well as the treatment of vascular lesions.
A highly innovative company, Cynosure currently holds 37 U.S. patents and markets over 14 different light based systems, representing advanced levels of solid-state, liquid and semiconductor laser technologies. Cynosure products are used by professionals in the aesthetic and medical markets on a worldwide basis.
Affirm
Affirm The Affirm Anti-Aging Workstation offers wrinkle reduction, scar treatment, pigmentation and redness reduction, age spot treatment, facial rejuvenation and coagulation of tissue resulting in tighter skin for overall younger looking skin. Affirm incorporates MultiPlex™ technology with Combined Apex Pulsesm (CAP) technology-the industry’s fastest laser-based energy source—and Xenon Pulsed Light (XPL) technology into one compact workstation.
The result? A complete skin rejuvenation solution that provides better and faster results with less pain than any other available product.
Elite
Elite Cynosure’s Elite Aesthetic Workstation is the most comprehensive laser hair removal system available today. Since it’s designed for all skin types, we can treat the broadest range of clients. In addition, the system is optimized for effective treatment of facial and leg veins, as well as benign epidermal pigmented lesions.
The Best of Both Worlds:
The Elite removes unwanted hair with unsurpassed efficacy and client comfort. That’s because its revolutionary technology combines two optimal wavelengths in one system: the 755-nm Alexandrite laser and the 1064-nm Nd:YAG laser.
Since we can switch between wavelengths during a single procedure, we can select the most appropriate laser for any given hair or skin type. We can also perform multiple procedures on the same client during the same visit.
MedLite® C6
Recognized as the industry’s gold standard for tattoo removal, the MedLite offers four wavelengths to target even stubborn multi-color tattoos. The 1064 nm and 532 nm treat red and dark ink tattoos including black, dark blue, brown, and purple. The additional wave¬lengths (585 nm and 650 nm) with the MultiLite Dye Handpieces treat more challenging colors including sky blue and green. The PhotoAcoustic waves of energy effectively shatter the tattoo ink into particle fragments that are gradually removed by the body’s natural pro¬cess. The MedLite removes tattoos with minimal risk of scarring or skin pigment changes.
The MedLite® C Series EO Q-switched laser utilizes the latest in multi-wavelength, articulated-arm-delivered laser technology. Representing the next generation of Q-switched technology, the MedLite® uses an electro-optic (EO) high-speed shutter to produce nanosecond pulse widths. Peak energy is dispersed throughout the epidermis faster than the relaxation time of the healthy tissue. The result is a PhotoAcoustic Therapy effect, a safe, effective way to deliver energy precisely where it is needed.
Zerona®
The ERCHONIA® Laser Scanner is specially designed for use during Liposuction and non-invasive body contouring (ZERONA®). The laser is applied externally and has proven through double blind clinical trials to emulsify adipose tissue.
ZERONA® is a new body-sculpting procedure designed to remove fat and contour the body without invasive surgery. ZERONA® unlike other procedures, allows the patient to continue their daily activities without interruptions from surgery, pain, wounds or garments. ZERONA® works by utilizing the Erchonia® Laser Scanner (FDA market cleared for laser assisted liposuction) to emulsify adipose tissue which then releases into the interstitial space. The excess fat is passed through the body during its normal course of detoxification. The ZERONA® procedure was proven through a double blind, randomized, multi-site, and placebo controlled study in which patients averaged a loss of 3-4 inches compared to the placebo group that lost only a half an inch.
